Table 2.
All the studied population | Group I negative control N = 10 | Group II nontreated NAFLD group model N = 11 | Group III positive control group N = 10 | Group IV NAFLD + vitamin D supplement N = 14 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
r | P | r | P | r | P | r | P | r | P | |
Weight (gm) | −0.85 | <0.001 | −0.24 | 0.51 | −0.30 | 0.29 | −0.23 | 0.53 | 0.13 | 0.71 |
Height (cm) | −0.13 | 0.60 | 0.19 | 0.60 | −0.25 | 0.39 | −0.48 | 0.17 | 0.04 | 0.81 |
BMI (gm/cm2) | −0.75 | <0.001 | −0.25 | 0.48 | 0.09 | 0.77 | 0.21 | 0.41 | 0.02 | 0.94 |
Hepatic index | 0.85 | <0.001 | 0.43 | 0.21 | 0.53 | 0.05 | 0.02 | 0.95 | 0.12 | 0.72 |
Insulin (μu/L) | −0.73 | <0.001 | 0.15 | 0.68 | 0.21 | 0.21 | −0.40 | 0.25 | −0.51 | 0.05 |
Glucose (mmol/L) | −0.71 | <0.001 | 0.64 | 0.05 | 0.26 | 0.38 | 0.05 | 0.89 | −0.23 | 0.41 |
HOMA-IR | −0.76 | <0.001 | 0.57 | 0.09 | 0.34 | 0.23 | −0.30 | 0.39 | −0.52 | 0.01 |
T Chol. (mmol/L) | −0.84 | <0.001 | 0.06 | 0.87 | −0.12 | 0.68 | 0.41 | 0.14 | −0.06 | 0.87 |
TG (mmol/L) | −0.51 | <0.001 | −0.23 | 0.53 | 0.23 | 0.42 | 0.20 | 0.58 | −0.04 | 0.97 |
LDL-C (mmol/L) | −0.59 | <0.001 | −0.46 | 0.18 | −0.70 | 0.00 | −0.26 | 0.47 | −0.35 | 0.32 |
HDL-C (mmol/L) | −0.57 | <0.001 | 0.13 | 0.72 | 0.12 | 0.78 | −0.31 | 0.38 | −0.18 | 0.62 |
Albumin (g/dl) | 0.16 | 0.21 | −0.67 | 0.03 | −0.38 | 0.18 | 0.47 | 0.18 | −0.10 | 0.76 |
AST (U/L) | −0.74 | <0.001 | 0.15 | 0.68 | 0.48 | 0.08 | 0.25 | 0.48 | −0.31 | 0.36 |
ALT (U/L) | −0.79 | <0.001 | 0.29 | 0.42 | 0.26 | 0.37 | 0.12 | 0.75 | 0.37 | 0.27 |
ALP (U/L) | 0.25 | 0.01 | 0.13 | 0.72 | 0.19 | 0.52 | −0.19 | 0.51 | 0.23 | 0.41 |
GGT (U/L) | −0.83 | <0.001 | −0.51 | 0.13 | 0.23 | 0.43 | −0.01 | 0.99 | −0.46 | 0.15 |
Statistical analysis was carried out using Spearman's correlation analysis. r = Spearman's rank correlation coefficient, ∗P-value ≤0.05 is considered significant.